DEFERIPRONE LIPOMED 500 mg, film-coated tablet 100 tablets
Active ingredients: DÉFÉRIPRONE
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet100 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DEFERIPRONE LIPOMED 500 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermosoudée(s) aluminium PVC PVDC de 100 comprimé(s)
- Marketing authorisation holder
- LIPOMED (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Apr 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66508896CIP73018253CIP133400930182536Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DÉFÉRIPRONEcomprimé | 500 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: DEFERIPRONE 500 mg - FERRIPROX 500 mg, comprimé pelliculé